Aaron Kesselheim

Dr. Aaron S. Kesselheim serves as Professor of Medicine at Harvard Medical School and Director of the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women's Hospital, where he has revolutionized research on pharmaceutical policy and regulation. With an exceptional academic background including degrees from Harvard College, University of Pennsylvania (MD, JD), and Harvard School of Public Health (MPH), he combines expertise in medicine, law, and public health. As founder of PORTAL, he has built one of the country's largest independent research centers focusing on drug policy and regulation. His prolific scholarship includes over 600 peer-reviewed publications, making him one of the most cited health law scholars in the US. Elected to the National Academy of Medicine in 2020, he serves as editor-in-chief of the Journal of Law, Medicine, and Ethics and holds visiting professorships at Yale Law School. His influence extends beyond academia through Congressional testimonies on pharmaceutical policy and his popular HarvardX course on drug regulation reaching over 100,000 participants worldwide. As a board-certified internist at the Phyllis Jen Center for Primary Care, he maintains active clinical practice while shaping national policy on drug development, pricing, and regulation.